Reports
Reports
Sale
The global MRSA testing market size is expected to grow at a CAGR of 12.20% during the forecast period of 2023-2028. The development of the market is driven by the continuous developments in diagnostic devices and the increasing prevalence of MRSA infections globally.
MRSA stands for methicillin-resistant Staphylococcus aureus, and is a type of bacteria that is resistant to some of the most widely used antibiotics. MRSA testing is a diagnostic procedure that is utilized to search for MRSA bacteria. The testing is done through a sample extracted from a wound, nostril, or other body fluids.
Based on test type, the market can be segmented into molecular diagnostic tests and immunodiagnostic tests. Based on the end-use, it can be bifurcated into hospitals, diagnostic and pathology centres, academic and research institutes, among others. The regional markets for the MSRA testing market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the MRSA testing companies, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
Based on end-use, the MRSA testing market is segmented into hospitals, diagnostic and pathology centres, academic and research institutes, among others. Among these segments, hospitals are expected to cover a major portion of the market.
This segment is likely to dominate the market during the forecast period owing to the first preference of people as a one-stop solution and the wide array of healthcare services provided. Also, the adoption of advanced technologies and diagnostic procedures is expected to further propel the market growth.
The major regions in the MRSA testing market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
North America is likely to be the dominating region in the global market owing to the growing awareness among people about MRSA infection and the testing methods provided by healthcare facility providers. The presence of established market players and increasing investments by the market players in research and development for the development of effective diagnostic methods can propel the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
F.Hoffmann-La Roche, more commonly known as Roche, is a Swiss healthcare company that operates globally in two market divisions including pharmaceuticals and diagnostics. It is one of the key players in the MRSA testing market. The company is a part of Roche Holding, its parent organization. The company's headquarter is located in Basel, Switzerland, and was founded in 1896. The company is focused on research and development, manufacture, and distribution of drugs related to diseases such as cancer, viral infections, metabolic, central nervous system disorders, and inflammatory diseases, among other healthcare products.
Hain Lifescience GmbH is a German-based modern and innovative diagnostic company that is engaged in the manufacturing and distribution of molecular diagnosis systems. The company operates with the aim to provide improved solutions for laboratories to enable reliable and sound diagnostics and provide the most relevant and optimal treatment to patients.
Becton, Dickinson and Company is one world’s largest medical technology manufacturing companies. The company has been operating since 1897 in the field of medical technology with an aim to improve world healthcare by innovating medical discovery, diagnostics, and delivery of medical care. The company's headquarter is located in New Jersey, United States. It specialises in various fields of healthcare including medical devices, biosciences, medical supplies, reagents, and diagnostics products, among many other related products.
Other market players include Alifax S.r.l., bioMérieux SA, ZeptoMetrix Corporation, and Abacus Diagnostica Oy, among others.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Test Type |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global MRSA Testing Market Analysis
8.1 Key Industry Highlights
8.2 Global MRSA Testing Historical Market (2018-2022)
8.3 Global MRSA Testing Market Forecast (2023-2028)
8.4 Global MRSA Testing Market by Test Type
8.4.1 Molecular Diagnostic Tests
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Immunodiagnostic Tests
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global MRSA Testing Market by End Use
8.5.1 Hospitals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Diagnostic and Pathology Centres
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Academic and Research Institutes
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global MRSA Testing Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
9 North America Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 F.Hoffmann-La Roche
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Hain Lifescience GmbH
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Becton, Dickinson and Company
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Alifax S.r.l.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 bioMérieux SA
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 ZeptoMetrix Corporation
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Abacus Diagnostica Oy
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global MRSA Testing Market: Key Industry Highlights, 2018 and 2028
2. Global MRSA Testing Historical Market: Breakup by Test Type (USD Million), 2018-2022
3. Global MRSA Testing Market Forecast: Breakup by Test Type (USD Million), 2023-2028
4. Global MRSA Testing Historical Market: Breakup by End Use (USD Million), 2018-2022
5. Global MRSA Testing Market Forecast: Breakup by End Use (USD Million), 2023-2028
6. Global MRSA Testing Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global MRSA Testing Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America MRSA Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe MRSA Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific MRSA Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America MRSA Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa MRSA Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global MRSA Testing Market Structure.
The market is expected to grow at a CAGR of 12.20% during the forecast period of 2023-2028.
The market is driven by the growing demand for advanced diagnostic and testing methods and increasing efforts for research and development by key players in the market.
The rising opportunities for growth in developing regions and growing awareness of MRSA infections and diagnostic methods are expected to deliver new growth opportunities to the market.
The regional markets for the global MRSA testing market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The test types available in the market are molecular diagnostic tests and immunodiagnostic tests.
MRSA testing is utilized by hospitals, diagnostic and pathology centres, academic and research institutes, among others.
The key players in the market include F.Hoffmann-La Roche, Hain Lifescience GmbH, Becton, Dickinson and Company, Alifax S.r.l., bioMérieux SA, ZeptoMetrix Corporation, and Abacus Diagnostica Oy, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.